Department of Biochemistry, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.
Laboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda 20892-0540, MD, USA.
Life Sci. 2022 Feb 15;291:120298. doi: 10.1016/j.lfs.2021.120298. Epub 2022 Jan 7.
Understanding human neurogenesis is critical toward regenerative medicine for neurodegeneration. However, little is known how neural differentiation is regulated by DEAD box-containing RNA helicases, which comprise a diverse class of RNA remodeling enzymes.
ChIP-seq was utilized to identify binding sites of DDX5 and DDX17 in both human pluripotent stem cell (hPSC) line NTERA2 and their retinoic acid-induced neural derivatives. RNA-seq was used to elucidate genes differentially expressed upon depletion of DDX5 and DDX17. Neurosphere assay, flow cytometry, and immunofluorescence staining were performed to test the effect of depletion of the two RNA helicases in neural differentiation.
We show here that expression of DDX5 and DDX17 is abundant throughout neural differentiation of NTERA2, and is mostly localized within the nucleus. The two RNA helicases occupy chromatin genome-wide at regions associated with neurogenesis-related genes in both hPSCs and their neural derivatives. Further, both DDX5 and DDX17 are mutually required for controlling transcriptional expression of these genes, but are not important for maintenance of stem cell state of hPSCs. In contrast, they facilitate early neural differentiation of hPSCs, generation of neurospheres from the stem cells, and transcriptional expression of key neurogenic transcription factors such as SOX1 and PAX6 during neural differentiation. Importantly, DDX5 and DDX17 are critical for differentiation of hPSCs toward NESTIN- and TUBB3-positive cells, which represent neural progenitors and mature neurons, respectively.
Collectively, our findings suggest the role of DDX5 and DDX17 in transcriptional regulation of genes involved in neurogenesis, and hence in neural differentiation of hPSCs.
理解人类神经发生对于神经退行性疾病的再生医学至关重要。然而,人们对 DEAD 框 RNA 解旋酶如何调节神经分化知之甚少,这些酶构成了一类多样化的 RNA 重塑酶。
利用 ChIP-seq 鉴定了 DDX5 和 DDX17 在人多能干细胞(hPSC)系 NTERA2 及其视黄酸诱导的神经衍生物中的结合位点。RNA-seq 用于阐明 DDX5 和 DDX17 缺失时差异表达的基因。神经球测定、流式细胞术和免疫荧光染色用于测试两种 RNA 解旋酶在神经分化中的缺失作用。
我们在此表明,DDX5 和 DDX17 的表达在 NTERA2 的神经分化过程中丰富,并且主要定位于核内。这两种 RNA 解旋酶在 hPSCs 及其神经衍生物中与神经发生相关基因相关的区域广泛占据染色质基因组。此外,这两种 RNA 解旋酶相互需要控制这些基因的转录表达,但对于维持 hPSC 的干细胞状态不重要。相比之下,它们促进 hPSC 的早期神经分化、从干细胞产生神经球,以及在神经分化过程中关键神经发生转录因子 SOX1 和 PAX6 的转录表达。重要的是,DDX5 和 DDX17 对于 hPSC 向 NESTIN 和 TUBB3 阳性细胞的分化至关重要,这两种细胞分别代表神经前体细胞和成熟神经元。
总的来说,我们的研究结果表明 DDX5 和 DDX17 在涉及神经发生的基因的转录调控中的作用,从而在 hPSC 的神经分化中发挥作用。